Skip to content
healthcare.dev

ZITUVIMET

NDC 70710-1787, Sitagliptin and Metformin Hydrochloride, tablet, film coated, from Zydus Pharmaceuticals (USA) Inc..

Product NDC
70710-1787
Status
Listed
Labeler
Zydus Pharmaceuticals (USA) Inc.
Dosage form
TABLET, FILM COATED
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
NDA
Application
NDA216743
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/70710-1787 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • SITAGLIPTIN50 mg/1
  • METFORMIN HYDROCHLORIDE1000 mg/1

Pharmacologic classes

Biguanide [EPC]; Biguanides [CS]; Dipeptidyl Peptidase 4 Inhibitor [EPC]; Dipeptidyl Peptidase 4 Inhibitors [MoA]

Package NDCNDC-11Package
70710-1787-67071017870660 TABLET, FILM COATED in 1 BOTTLE (70710-1787-6)
70710-1787-870710178708180 TABLET, FILM COATED in 1 BOTTLE (70710-1787-8)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/eeda90a0-4941-4716-8684-f9f12cbdf3af
  • NADAC price for package 70710178706

    GET /v1/drugs/nadac/70710178706

Use it

Look up 70710-1787 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/70710-1787 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 70710-1787. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.